Andrew Ustianowski, MD, PhD

North Manchester General Hospital, United Kingdom

Disclosure(s): Gilead: Advisor/Consultant, Board Member, Honoraria, Speaker fees; Pfizer: Honoraria, Speaker fees; Vir/GlaxoSmithKline: Advisor/Consultant, Board Member

Poster(s):

• 1974 - Title: A novel low-dose self-amplifying mRNA vaccine (GRT-R910) induces strong and broad boost in cellular and humoral immune response following primary series with a chimpanzee adenovirus SARS-CoV-2 vaccination
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET